Pharmaceutical
mercredi 12 novembre 2014
Xeljanz ACR poster 487?
Am I reading this right? The QD version is just as damaging to LCL-C, HDL-C and TG as the BID version? Why are we presenting this?
Xeljanz ACR poster 487?
Aucun commentaire:
Enregistrer un commentaire
Article plus récent
Article plus ancien
Accueil
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire